期刊文献+

经胸阻抗监测在慢性心力衰竭患者中的临床应用观察

Clinical utility of intrathoracic impedance monitoring in patients with chronic heart failure
原文传递
导出
摘要 目的评估植入性器械经胸阻抗监测功能识别慢性心力衰竭患者中液体潴留的有效性。方法对10例植入带有经胸阻抗监测功能植入式器械的慢性心力衰竭患者进行定期随访,观察经胸阻抗的变化,并分析其可能原因。结果10例患者出现经胸阻抗的变化并达液体潴留报警阈值水平4例共7次报警,生活方式变化、停用抗心力衰竭药物、感染及再次植入术引起各1次,另3次为心功能下降所致。结论经胸阻抗监测在慢性心力衰竭患者中是一项有用的工具,能尽早预警心力衰竭患者的失代偿。 Objective The aim of this study is to evaluate the implantable device capable of measuring iutrathoracic impedance to identify potential fluid overload before heart failure hospitalization. Methods Ten patients with chronic heart failure were implanted with a special implantable device which can measure intrathoracic impedance. The data of impedance were retrospectively identified before and after device implantation during follow-up. And analyses of impedance as well as the reasons of impedance changes were performed. Results Four patients experienced 7 intrathoracie impedance fluid index threshold crossing events at nominal threshold value( 60Ω) during follow-up in all 10 patients. The occurrence of threshold crossing events was associated with life style change, stop taking anti-heart failure drug, infection, and re-implanted operation through alert events analysis. Three patients experienced heart failure deterioration. Conclusion The intrathoracie impedance monitoring is a useful tool for the clinical management of heart failure patients. Monitoring of impedance may provide early warning of impending decompensation and diagnostic information for titration of medication.
机构地区 浙江医院心内科
出处 《中华心律失常学杂志》 2011年第2期87-89,共3页 Chinese Journal of Cardiac Arrhythmias
关键词 经胸阻抗监测 慢性心力衰竭 Intrathoracic impedance monitoring Chronic heart failure
  • 相关文献

参考文献8

  • 1王方正,张澍,任自文,郭继鸿,胡大一,陈新,中华医学会心电生理和起搏分会及中国生物医学工程学会心脏起搏与电生理分会ICD专家工作组.植入型心律转复除颤器治疗的适应证[J].中华心律失常学杂志,2002,6(4):198-206. 被引量:29
  • 2Sahalos JN, Nieolaidis A, Gotsis N. The electrica/ impedance of the human thorax as a guide in evaluation of intrathoracic fluid volume. Physi Med Biol, 1986,31:425-439.
  • 3Baker LE, Dannistion JC. Noninvasive measurement of intrathoacic fluids. Chest, 1974,65 ( suppl ) :35S-37S.
  • 4Jonsson F, Madsen P, Jorgensen LG, et al. Thoracic electrical impedance and fluid balance during aortic surgery. Acta Anaesthesiologica Scandinavica, 1995,39:513-517.
  • 5Wang L. Fundamentals of intrathoracic impedance monitoring in heart failure. Am J Cardiol,2007,99(suppl) :3G-10G.
  • 6Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure:correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation ,2005, 112 .841-848.
  • 7Adamson PB, Smith AL, Abraham WT, et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by and implanted cardiac resynchronization device. Circulation ,2004,110:2389-2394.
  • 8Maines M, Catanzariti D, Cemin C, et al. Usefulness of intrathoracic fluids accumulation monitoring with and implantable biventrlcular defibrillator in reducing hospitalization in patients with heart fail- ure:a case-control study. J Interv Card Electrophyslol, 2007, 19 : 201-207.

二级参考文献60

  • 1Mower MM, Swerdlow C, Mandel WJ, et al. Use of the automatic implantable cardiovertor defibrillators in the treatment of malignant ventricular tachyarrhythmias. In: Willium J Mander, ed. Cardiac Arrhythmias: Their Mechanism, Diagnosis, and Management. 3rd ed. Philadelphia: J B Lippingcott Company, 1995.
  • 2Mirowski M, Mower MM, Staewen WS, et al. Standby automatic defibrillator: An approach to prevention of sudden coronary death. Arch Intern Med, 1970, 126: 150161.
  • 3Wichter T, Block M, Bocker D, et al. Cardioverter defibrillator therapy in a high risk subgroup of patients with arrhythmogenic right ventricular disease. J Am Coll Cardiol, 1993, 21:127A.
  • 4Maron BJ, Fananapazir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation, 1992, 85 (Suppl Ⅰ ) :157-163.
  • 5Kaminer SJ, Pickoff AS, Dunnigan A, et al. Cardiomyopathy and the use of implanted cardiac-defibrillators in children. Pacing Clin Electrophysiol, 1990, 13:593597.
  • 6Brugada P, Brugada J. Right bundle-branch block, persistent ST segment elevation and sundden cardiac death:distinct clinical and electrocardiography syndrom. A multicenter report. J Am Coll Cardiol, 1992, 20: 13911396.
  • 7Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST segment elevation in lead V1, through V3:a marker for sudden death in patients without demonstrable structural heart disease. Circulation, 1998, 47: 457460.
  • 8Brugada P, Brugada R, Brugada J. Sudden death in patients and relatives with the syndrome of right bundle branch block. ST segment elevation in the precordial leads V1 to V3 and sudden death. Eur Heart J, 2000, 21:321-326.
  • 9Atratashi H, Dgawa S, Harumi K, et al. Characteristic of patients with right bundle-branch block and ST segment elevation in right precordial leads. Am J Cardiol, 1996,78: 581-583.
  • 10Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implantable automatic defibrillator in human beings. N Engl J Med,1980, 303: 322-324.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部